EZH2 and esophageal squamous cell carcinoma: CASC9 promotes ESCC growth by regulating the EZH2/CASC9 pathway [18], while KLF3-AS1 inhibits ESCC tumorigenesis by regulating the miR-185-5p/KLF3 axis [19].